(Q63816334)
Statements
A Phase II, Double-Blind, Randomized, Three-Way Crossover, Placebo-Controlled, Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis on Standard Therapy (English)
0 references
December 2010
0 references
October 2012
0 references
32
0 references
18 year
0 references
80 year
0 references